| Reference |
|---|
Irie M, Kabata H, Sasahara K, Kurihara M, Shirasaki Y, Kamatani T, et al. Annexin A1 is a cell-intrinsic metalloregulator of zinc in human ILC2s. Cell Rep. 2023;42:112610 pubmed publisher |
Papotto P, Yilmaz B, Pimenta G, Mensurado S, Cunha C, Fiala G, et al. Maternal γδ T cells shape offspring pulmonary type 2 immunity in a microbiota-dependent manner. Cell Rep. 2023;42:112074 pubmed publisher |
Gurram R, Wei D, Yu Q, Butcher M, Chen X, Cui K, et al. Crosstalk between ILC2s and Th2 cells varies among mouse models. Cell Rep. 2023;42:112073 pubmed publisher |
Cheng L, Jiao Y, Jiang W, Zhang X, Zhang L, Jia G. IL-33 Deficiency Attenuates Lung Inflammation by Inducing Th17 Response and Impacting the Th17/Treg Balance in LPS-Induced ARDS Mice via Dendritic Cells. J Immunol Res. 2022;2022:9543083 pubmed publisher |
Zhao M, Shao F, Yu D, Zhang J, Liu Z, Ma J, et al. Maturation and specialization of group 2 innate lymphoid cells through the lung-gut axis. Nat Commun. 2022;13:7600 pubmed publisher |
Block K, Iijima K, Pierson M, Walsh D, Tei R, Kucaba T, et al. Physiological microbial exposure transiently inhibits mouse lung ILC2 responses to allergens. Nat Immunol. 2022;23:1703-1713 pubmed publisher |
Badrani J, Strohm A, Lacasa L, Civello B, Cavagnero K, Haung Y, et al. RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1R. Nat Commun. 2022;13:4435 pubmed publisher |
Lee H, Park H. IL-23 plays a significant role in the augmentation of particulate matter-mediated allergic airway inflammation. J Cell Mol Med. 2022;26:4506-4519 pubmed publisher |
Sheikh A, Lu J, Melese E, Seo J, Abraham N. IL-7 induces type 2 cytokine response in lung ILC2s and regulates GATA3 and CD25 expression. J Leukoc Biol. 2022;112:1105-1113 pubmed publisher |
Doke T, Abedini A, Aldridge D, Yang Y, Park J, Hernández C, et al. Single-cell analysis identifies the interaction of altered renal tubules with basophils orchestrating kidney fibrosis. Nat Immunol. 2022;23:947-959 pubmed publisher |
Cardoso F, Klein Wolterink R, Godinho Silva C, Domingues R, Ribeiro H, da Silva J, et al. Neuro-mesenchymal units control ILC2 and obesity via a brain-adipose circuit. Nature. 2021;597:410-414 pubmed publisher |
Suzuki Y, Hayashi T, Yokoyama R, Nakagawa F, Inoue J, Higashi T, et al. Fasting impairs type 2 helper T cell infiltration in the lung of an eosinophilic asthma mouse model. FEBS Open Bio. 2021;11:2619-2630 pubmed publisher |
Patial S, Lewis B, Vo T, Choudhary I, Paudel K, Mao Y, et al. Myeloid-IL4Rα is an indispensable link in IL-33-ILCs-IL-13-IL4Rα axis of eosinophil recruitment in murine lungs. Sci Rep. 2021;11:15465 pubmed publisher |
de Lucía Finkel P, Sherwood C, Saranchova I, Xia W, Munro L, Pfeifer C, et al. Serum free culture for the expansion and study of type 2 innate lymphoid cells. Sci Rep. 2021;11:12233 pubmed publisher |
Morichika D, Taniguchi A, Oda N, Fujii U, Senoo S, Itano J, et al. Loss of IL-33 enhances elastase-induced and cigarette smoke extract-induced emphysema in mice. Respir Res. 2021;22:150 pubmed publisher |
Kotas M, Dion J, Van Dyken S, Ricardo Gonzalez R, Danel C, Taillé C, et al. A role for IL-33-activated ILC2s in eosinophilic vasculitis. JCI Insight. 2021;6: pubmed publisher |
Zheng C, Lu Z, Wu H, Cui L, Bi J, Wan X. Exogenous oxidative stress suppresses IL-33 -driven proliferation programming in group 2 innate lymphoid cells. Int Immunopharmacol. 2021;95:107541 pubmed publisher |
Arae K, Ikutani M, Horiguchi K, Yamaguchi S, Okada Y, Sugiyama H, et al. Interleukin-33 and thymic stromal lymphopoietin, but not interleukin-25, are crucial for development of airway eosinophilia induced by chitin. Sci Rep. 2021;11:5913 pubmed publisher |
Alonso Curbelo D, Ho Y, Burdziak C, Mååg J, Morris J, Chandwani R, et al. A gene-environment-induced epigenetic program initiates tumorigenesis. Nature. 2021;: pubmed publisher |
Baban B, Braun M, Khodadadi H, Ward A, Alverson K, Malik A, et al. AMPK induces regulatory innate lymphoid cells after traumatic brain injury. JCI Insight. 2021;6: pubmed publisher |
Huang J, Gandini M, Chen L, M Dahoma S, Stemkowski P, Chung H, et al. Hyperactivity of Innate Immunity Triggers Pain via TLR2-IL-33-Mediated Neuroimmune Crosstalk. Cell Rep. 2020;33:108233 pubmed publisher |
Reverchon F, de Concini V, Larrigaldie V, Benmerzoug S, Briault S, Togbe D, et al. Hippocampal interleukin-33 mediates neuroinflammation-induced cognitive impairments. J Neuroinflammation. 2020;17:268 pubmed publisher |
Inclan Rico J, Ponessa J, Valero Pacheco N, Hernández C, Sy C, Lemenze A, et al. Basophils prime group 2 innate lymphoid cells for neuropeptide-mediated inhibition. Nat Immunol. 2020;21:1181-1193 pubmed publisher |
Bosteels C, Neyt K, Vanheerswynghels M, Van Helden M, Sichien D, Debeuf N, et al. Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection. Immunity. 2020;52:1039-1056.e9 pubmed publisher |
Takenaga K, Akimoto M, Koshikawa N, Nagase H. Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model. PLoS ONE. 2020;15:e0232230 pubmed publisher |
Vasanthakumar A, Chisanga D, Blume J, Gloury R, Britt K, Henstridge D, et al. Sex-specific adipose tissue imprinting of regulatory T cells. Nature. 2020;579:581-585 pubmed publisher |
Wagner M, Ealey K, Tetsu H, Kiniwa T, Motomura Y, Moro K, et al. Tumor-Derived Lactic Acid Contributes to the Paucity of Intratumoral ILC2s. Cell Rep. 2020;30:2743-2757.e5 pubmed publisher |
Lin L, Tang X, Chen Z, Wei J, Dai F, Sun G. Nuocytes from mesenteric lymph node promote allergic responses in a mouse model. Braz J Otorhinolaryngol. 2020;: pubmed publisher |
Moral J, Leung J, Rojas L, Ruan J, Zhao J, Sethna Z, et al. ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity. Nature. 2020;579:130-135 pubmed publisher |
Hsu C, Chhiba K, Krier Burris R, Hosakoppal S, Berdnikovs S, Miller M, et al. Allergic inflammation is initiated by IL-33-dependent crosstalk between mast cells and basophils. PLoS ONE. 2020;15:e0226701 pubmed publisher |
Miki H, Tahara Hanaoka S, Almeida M, Hitomi K, Shibagaki S, Kanemaru K, et al. Allergin-1 Immunoreceptor Suppresses House Dust Mite-Induced Allergic Airway Inflammation. J Immunol. 2020;204:753-762 pubmed publisher |
Oyesola O, Duque C, Huang L, Larson E, Früh S, Webb L, et al. The Prostaglandin D2 Receptor CRTH2 Promotes IL-33-Induced ILC2 Accumulation in the Lung. J Immunol. 2020;204:1001-1011 pubmed publisher |
Ishimaru K, Nakajima S, Yu G, Nakamura Y, Nakao A. The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock. Int J Mol Sci. 2019;20: pubmed publisher |
Mantani P, Dunér P, Ljungcrantz I, Nilsson J, Bjorkbacka H, Fredrikson G. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions. BMC Immunol. 2019;20:47 pubmed publisher |
Mishima Y, Sonoyama H, Ishihara S, Oshima N, Moriyama I, Kawashima K, et al. Interleukin-33 delays recovery of mucosal inflammation via downregulation of homeostatic ABCG5/8 in the colon. Lab Invest. 2020;100:491-502 pubmed publisher |
Sasaki T, Moro K, Kubota T, Kubota N, Kato T, Ohno H, et al. Innate Lymphoid Cells in the Induction of Obesity. Cell Rep. 2019;28:202-217.e7 pubmed publisher |
Zychlinsky Scharff A, Rousseau M, Lacerda Mariano L, Canton T, Consiglio C, Albert M, et al. Sex differences in IL-17 contribute to chronicity in male versus female urinary tract infection. JCI Insight. 2019;5: pubmed publisher |
Symowski C, Voehringer D. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice. Eur J Immunol. 2019;49:1421-1432 pubmed publisher |
Morales Del Valle C, Maxwell J, Xu M, Menoret A, Mittal P, Tsurutani N, et al. Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like Mechanism. Cell Rep. 2019;27:1434-1445.e3 pubmed publisher |
Katsura H, Kobayashi Y, Tata P, Hogan B. IL-1 and TNFα Contribute to the Inflammatory Niche to Enhance Alveolar Regeneration. Stem Cell Reports. 2019;12:657-666 pubmed publisher |
Cho H, Reboldi A, Hall J, Berg L. The Tec kinase ITK is essential for ILC2 survival and epithelial integrity in the intestine. Nat Commun. 2019;10:784 pubmed publisher |
Weinberg E, Ferrán B, Tsukahara Y, Hatch M, Han J, Murdoch C, et al. IL-33 induction and signaling are controlled by glutaredoxin-1 in mouse macrophages. PLoS ONE. 2019;14:e0210827 pubmed publisher |
Koliaraki V, Chalkidi N, Henriques A, Tzaferis C, Polykratis A, Waisman A, et al. Innate Sensing through Mesenchymal TLR4/MyD88 Signals Promotes Spontaneous Intestinal Tumorigenesis. Cell Rep. 2019;26:536-545.e4 pubmed publisher |
Uchida R, Xiang H, Arai H, Kitamura H, Nishida K. L-Type Calcium Channel-Mediated Zinc Wave Is Involved in the Regulation of IL-6 by Stimulating Non-IgE with LPS and IL-33 in Mast Cells and Dendritic Cells. Biol Pharm Bull. 2019;42:87-93 pubmed publisher |
Filbey K, Camberis M, Chandler J, Turner R, Kettle A, Eichenberger R, et al. Intestinal helminth infection promotes IL-5- and CD4+ T cell-dependent immunity in the lung against migrating parasites. Mucosal Immunol. 2019;12:352-362 pubmed publisher |
Liu N, Jiang Y, Chen J, Nan H, Zhao Y, Chu X, et al. IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells. Cell Mol Immunol. 2018;: pubmed publisher |
Ricardo Gonzalez R, Van Dyken S, Schneider C, Lee J, Nussbaum J, Liang H, et al. Tissue signals imprint ILC2 identity with anticipatory function. Nat Immunol. 2018;19:1093-1099 pubmed publisher |
Varanasi S, Rajasagi N, Jaggi U, Rouse B. Role of IL-18 induced Amphiregulin expression on virus induced ocular lesions. Mucosal Immunol. 2018;11:1705-1715 pubmed publisher |
Cao K, Liao X, Lu J, Yao S, Wu F, Zhu X, et al. IL-33/ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation. J Neuroinflammation. 2018;15:136 pubmed publisher |
Kobori T, Hamasaki S, Kitaura A, Yamazaki Y, Nishinaka T, Niwa A, et al. Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis. Front Immunol. 2018;9:334 pubmed publisher |
Sun B, Zhu L, Tao Y, Sun H, Li Y, Wang P, et al. Characterization and allergic role of IL-33-induced neutrophil polarization. Cell Mol Immunol. 2018;15:782-793 pubmed publisher |
An G, Zhang X, Wang W, Huang Q, Li Y, Shan S, et al. The effects of interleukin-33 on airways collagen deposition and matrix metalloproteinase expression in a murine surrogate of asthma. Immunology. 2018;: pubmed publisher |
Li Q, Li D, Zhang X, Wan Q, Zhang W, Zheng M, et al. E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function via Glycolysis Inhibition and Induction of Interleukin-33 Receptor. Immunity. 2018;48:258-270.e5 pubmed publisher |
Nishioka I, Takai T, Maruyama N, Kamijo S, Suchiva P, Suzuki M, et al. Airway inflammation after epicutaneous sensitization of mice requires protease activity of low-dose allergen inhalation. J Allergy Clin Immunol. 2018;141:2271-2273.e7 pubmed publisher |
Yamaguchi M, Samuchiwal S, Quehenberger O, Boyce J, Balestrieri B. Macrophages regulate lung ILC2 activation via Pla2g5-dependent mechanisms. Mucosal Immunol. 2018;11:615-626 pubmed publisher |
Duffen J, Zhang M, Masek Hammerman K, Nuñez A, Brennan A, Jones J, et al. Modulation of the IL-33/IL-13 Axis in Obesity by IL-13Rα2. J Immunol. 2018;200:1347-1359 pubmed publisher |
Cardoso V, Chesne J, Ribeiro H, García Cassani B, Carvalho T, Bouchery T, et al. Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. Nature. 2017;549:277-281 pubmed publisher |
Garth J, Reeder K, Godwin M, Mackel J, Dunaway C, Blackburn J, et al. IL-33 Signaling Regulates Innate IL-17A and IL-22 Production via Suppression of Prostaglandin E2 during Lung Fungal Infection. J Immunol. 2017;199:2140-2148 pubmed publisher |
Han M, Rajput C, Hong J, Lei J, Hinde J, Wu Q, et al. The Innate Cytokines IL-25, IL-33, and TSLP Cooperate in the Induction of Type 2 Innate Lymphoid Cell Expansion and Mucous Metaplasia in Rhinovirus-Infected Immature Mice. J Immunol. 2017;199:1308-1318 pubmed publisher |
Taylor S, Huang Y, Mallett G, Stathopoulou C, Felizardo T, Sun M, et al. PD-1 regulates KLRG1+ group 2 innate lymphoid cells. J Exp Med. 2017;214:1663-1678 pubmed publisher |
Reverchon F, Mortaud S, Sivoyon M, Maillet I, Laugeray A, Palomo J, et al. IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria. PLoS Pathog. 2017;13:e1006322 pubmed publisher |
Sezaki T, Hirata Y, Hagiwara T, Kawamura Y, Okamura T, Takanashi R, et al. Disruption of the TWEAK/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice. World J Gastroenterol. 2017;23:2294-2307 pubmed publisher |
Ikutani M, Tsuneyama K, Kawaguchi M, Fukuoka J, Kudo F, Nakae S, et al. Prolonged activation of IL-5-producing ILC2 causes pulmonary arterial hypertrophy. JCI Insight. 2017;2:e90721 pubmed publisher |
Bi J, Cui L, Yu G, Yang X, Chen Y, Wan X. NK Cells Alleviate Lung Inflammation by Negatively Regulating Group 2 Innate Lymphoid Cells. J Immunol. 2017;198:3336-3344 pubmed publisher |
Abad M, Hashimoto H, Zhou H, Morales M, Chen B, Bassel Duby R, et al. Notch Inhibition Enhances Cardiac Reprogramming by Increasing MEF2C Transcriptional Activity. Stem Cell Reports. 2017;8:548-560 pubmed publisher |
Tan Z, Liu Q, Jiang R, Lv L, Shoto S, Maillet I, et al. Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells. Cell Mol Immunol. 2018;15:388-398 pubmed publisher |
von Moltke J, O Leary C, Barrett N, Kanaoka Y, Austen K, Locksley R. Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. J Exp Med. 2017;214:27-37 pubmed publisher |
Lapérine O, Cloitre A, Caillon J, Huck O, Bugueno I, Pilet P, et al. Interleukin-33 and RANK-L Interplay in the Alveolar Bone Loss Associated to Periodontitis. PLoS ONE. 2016;11:e0168080 pubmed publisher |
Sektioglu I, Carretero R, Bulbuc N, Bald T, Tüting T, Rudensky A, et al. Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells. Cancer Res. 2017;77:291-302 pubmed publisher |
Neumann K, Karimi K, Meiners J, Voetlause R, Steinmann S, Dammermann W, et al. A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis. J Immunol. 2017;198:128-137 pubmed |
Liu B, Tai Y, Achanta S, Kaelberer M, Caceres A, Shao X, et al. IL-33/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy. Proc Natl Acad Sci U S A. 2016;113:E7572-E7579 pubmed |
Biton J, Khaleghparast Athari S, Thiolat A, Santinon F, Lemeiter D, Hervé R, et al. In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis. J Immunol. 2016;197:1708-19 pubmed publisher |
Peng H, Zhang Q, Li X, Liu Z, Shen J, Sun R, et al. IL-33 Contributes to Schistosoma japonicum-induced Hepatic Pathology through Induction of M2 Macrophages. Sci Rep. 2016;6:29844 pubmed publisher |
Ibiza S, García Cassani B, Ribeiro H, Carvalho T, Almeida L, Marques R, et al. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature. 2016;535:440-443 pubmed publisher |
Kempuraj D, Thangavel R, Yang E, Pattani S, Zaheer S, Santillan D, et al. Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators. PLoS ONE. 2015;10:e0135776 pubmed publisher |
Monticelli L, Osborne L, Noti M, Tran S, Zaiss D, Artis D. IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. Proc Natl Acad Sci U S A. 2015;112:10762-7 pubmed publisher |
Mohapatra A, Van Dyken S, Schneider C, Nussbaum J, Liang H, Locksley R. Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis. Mucosal Immunol. 2016;9:275-86 pubmed publisher |
Nabekura T, Girard J, Lanier L. IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection. J Immunol. 2015;194:5948-52 pubmed publisher |
Yamada K, Barker T, Dyer K, Rice T, Percopo C, Garcia Crespo K, et al. Eosinophil-associated ribonuclease 11 is a macrophage chemoattractant. J Biol Chem. 2015;290:8863-75 pubmed publisher |
Brestoff J, Kim B, Saenz S, Stine R, Monticelli L, Sonnenberg G, et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature. 2015;519:242-6 pubmed publisher |
Rizvi S, Mertens J, Bronk S, Hirsova P, Dai H, Roberts L, et al. Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis. J Biol Chem. 2014;289:22835-49 pubmed publisher |
Hara K, Iijima K, Elias M, Seno S, Tojima I, Kobayashi T, et al. Airway uric acid is a sensor of inhaled protease allergens and initiates type 2 immune responses in respiratory mucosa. J Immunol. 2014;192:4032-42 pubmed publisher |
McSorley H, Blair N, Smith K, McKenzie A, Maizels R. Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy. Mucosal Immunol. 2014;7:1068-78 pubmed publisher |
Yu X, Pappu R, Ramirez Carrozzi V, Ota N, Caplazi P, Zhang J, et al. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol. 2014;7:730-40 pubmed publisher |
Palm N, Rosenstein R, Yu S, Schenten D, Florsheim E, Medzhitov R. Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity. 2013;39:976-85 pubmed publisher |
Jovanovic I, Pejnovic N, Radosavljevic G, Pantic J, Milovanovic M, Arsenijevic N, et al. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells. Int J Cancer. 2014;134:1669-82 pubmed publisher |
Gao Y, Nish S, Jiang R, Hou L, Licona Limón P, Weinstein J, et al. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity. 2013;39:722-32 pubmed publisher |
Tung H, Plunkett B, Huang S, Zhou Y. Murine mast cells secrete and respond to interleukin-33. J Interferon Cytokine Res. 2014;34:141-7 pubmed publisher |
Yang Z, Grinchuk V, Urban J, Bohl J, Sun R, Notari L, et al. Macrophages as IL-25/IL-33-responsive cells play an important role in the induction of type 2 immunity. PLoS ONE. 2013;8:e59441 pubmed publisher |
Sandig H, Jobbings C, Roldan N, Whittingham Dowd J, Orinska Z, Takeuchi O, et al. IL-33 causes selective mast cell tolerance to bacterial cell wall products by inducing IRAK1 degradation. Eur J Immunol. 2013;43:979-88 pubmed publisher |
Mizutani N, Nabe T, Yoshino S. Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice. Immunology. 2013;139:205-18 pubmed publisher |
Kaieda S, Wang J, Shnayder R, Fishgal N, Hei H, Lee R, et al. Interleukin-33 primes mast cells for activation by IgG immune complexes. PLoS ONE. 2012;7:e47252 pubmed publisher |
Willart M, Deswarte K, Pouliot P, Braun H, Beyaert R, Lambrecht B, et al. Interleukin-1? controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med. 2012;209:1505-17 pubmed publisher |
Freeman B, Hammarlund E, Raué H, Slifka M. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc Natl Acad Sci U S A. 2012;109:9971-6 pubmed publisher |
Klein Wolterink R, Kleinjan A, van Nimwegen M, Bergen I, de Bruijn M, Levani Y, et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol. 2012;42:1106-16 pubmed publisher |
Casey K, Fraser K, Schenkel J, Moran A, Abt M, Beura L, et al. Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J Immunol. 2012;188:4866-75 pubmed publisher |
Bartemes K, Iijima K, Kobayashi T, Kephart G, McKenzie A, Kita H. IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol. 2012;188:1503-13 pubmed publisher |
Monticelli L, Sonnenberg G, Abt M, Alenghat T, Ziegler C, Doering T, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol. 2011;12:1045-54 pubmed publisher |
Anthony R, Kobayashi T, Wermeling F, Ravetch J. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature. 2011;475:110-3 pubmed publisher |
Besnard A, Togbe D, Guillou N, Erard F, Quesniaux V, Ryffel B. IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur J Immunol. 2011;41:1675-86 pubmed publisher |
Louten J, Rankin A, Li Y, Murphy E, Beaumont M, Moon C, et al. Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation. Int Immunol. 2011;23:307-15 pubmed publisher |
Yasuoka S, Kawanokuchi J, Parajuli B, Jin S, Doi Y, Noda M, et al. Production and functions of IL-33 in the central nervous system. Brain Res. 2011;1385:8-17 pubmed publisher |
Bourgeois E, Levescot A, Diem S, Chauvineau A, Berges H, Milpied P, et al. A natural protective function of invariant NKT cells in a mouse model of innate-cell-driven lung inflammation. Eur J Immunol. 2011;41:299-305 pubmed publisher |
Kayamuro H, Yoshioka Y, Abe Y, Arita S, Katayama K, Nomura T, et al. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J Virol. 2010;84:12703-12 pubmed publisher |
Price A, Liang H, Sullivan B, Reinhardt R, Eisley C, Erle D, et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A. 2010;107:11489-94 pubmed publisher |
Neill D, Wong S, Bellosi A, Flynn R, Daly M, Langford T, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010;464:1367-70 pubmed publisher |
Ohno T, Oboki K, Kajiwara N, Morii E, Aozasa K, Flavell R, et al. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J Immunol. 2009;183:7890-7 pubmed publisher |
Perrigoue J, Saenz S, Siracusa M, Allenspach E, Taylor B, Giacomin P, et al. MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat Immunol. 2009;10:697-705 pubmed publisher |
Bourgeois E, Van L, Samson M, Diem S, Barra A, Roga S, et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol. 2009;39:1046-55 pubmed publisher |
Palmer G, Talabot Ayer D, Lamacchia C, Toy D, Seemayer C, Viatte S, et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum. 2009;60:738-49 pubmed publisher |
Hudson C, Christophi G, Gruber R, Wilmore J, Lawrence D, Massa P. Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol. 2008;84:631-43 pubmed publisher |
